Aortic stiffness as a surrogate endpoint to microand macrovascular complications in patients with type 2 diabetes

International Journal of Molecular Sciences

Volumn 17, Issue 12, 2016, Pages

  Cardoso, Claudia R L ^a   Salles, Gil F ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Arterial stiffness; Carotid femoral pulse wave velocity; Microvascular and macrovascular complications; Type 2 diabetes

Indexed keywords

ALBUMINURIA; ARTERIAL STIFFNESS; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; DIABETIC NEPHROPATHY; GLYCEMIC CONTROL; HUMAN; INFLAMMATION; MACROVASCULAR COMPLICATION; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PULSE WAVE; REVIEW; WEIGHT REDUCTION; ARTERY; COMPLICATION; FEMALE; MALE; PHYSIOLOGY;

ARTERIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 85004075750     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17122044     Document Type: Review

References (73)

1. Laurent, S., Boutouyrie, P. Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension 2007, 49, 1202-1206. [CrossRef] [PubMed]
2. Cavalcante, J.L., Lima, J.A., Redheuil, A., Al-Mallah, M.H. Aortic stiffness: Current understanding and future directions. J. Am. Coll. Cardiol. 2011, 57, 1511-1522. [CrossRef] [PubMed]
3. Cecelja, M., Chowienczyk, P. Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: A systematic review. Hypertension 2009, 54, 1328-1336. [CrossRef] [PubMed]
4. Laurent, S., Cockcroft, J., van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., Pannier, B., Vlachopoulos, C., Wilkinson, I., Struijker-Boudier, H. Expert consensus document on arterial stiffness: Methodological issues and clinical applications. Eur. Heart J. 2006, 27, 2588-2605. [CrossRef] [PubMed]
5. Boutouyrie, P., Fliser, D., Goldsmith, D., Covic, A., Wiecek, A., Ortiz, A., Martinez-Castelao, A., Lindholm, B., Massy, Z.A., Suleymanlar, G., et al. Assessment of arterial stiffness for clinical and epidemiological studies: Methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry. Nephrol. Dial. Transplant. 2014, 29, 232-239. [CrossRef] [PubMed]
6. Laurent, S., Boutouyrie, P., Asmar, R., Gautier, I., Laloux, B., Guize, L., Ducimetiere, P., Benetos, A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37, 1236-1241. [CrossRef] [PubMed]
7. Mattace-Raso, F.U., van der Cammen, T.J., Hofman, A., van Popele, N.M., Bos, M.L., Schalekamp, M.A., Asmar, R., Reneman, R.S., Hoeks, A.P., Breteler, M.M., et al. Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam study. Circulation 2006, 113, 657-663. [CrossRef] [PubMed]
8. Cardoso, C.R., Ferreira, M.T., Leite, N.C., Salles, G.F. Prognostic impact of aortic stiffness in high-risk type 2 diabetic patients: The Rio de Janeiro type 2 diabetes cohort study. Diabetes Care 2013, 36, 3772-3778. [CrossRef] [PubMed]
9. Wijkman, M., Länne, T., Östgren, C.J., Nystrom, F.H. Aortic pulse wave velocity predicts incident cardiovascular events in patients with type 2 diabetes treated in primary care. J. Diabetes Complicat. 2016, 30, 1223-1228. [CrossRef] [PubMed]
10. Ben-Shlomo, Y., Spears, M., Boustred, C., May, M., Anderson, S.G., Benjamin, E.J., Boutouyrie, P., Cameron, J., Chen, C.H., Cruickshank, J.K., et al. Aortic pulse wave velocity improves cardiovascular event prediction: An individual participant meta-analysis of prospective observational data from 17,635 subjects. J. Am. Coll. Cardiol. 2014, 63, 636-646. [CrossRef] [PubMed]
11. Munakata, M. Brachial-ankle pulse wave velocity: Background, method, and clinical evidence. Pulse (Basel) 2016, 3, 195-204. [CrossRef] [PubMed]
12. Miyoshi, T., Ito, H. Assessment of arterial stiffness using the cardio-ankle vascular index. Pulse (Basel) 2016, 4, 11-23. [CrossRef] [PubMed]
13. Huybrechts, S.A., Devos, D.G., Vermeersch, S.J., Mahieu, D., Achten, E., de Backer, T.L., Segers, P., van Bortel, L.M. Carotid to femoral pulse wave velocity: A comparison of real travelled aortic path length determined by MRI and superficial measurements. J. Hypertens. 2011, 29, 1577-1582. [CrossRef] [PubMed]
14. Taniwaki, H., Kawagishi, T., Emoto, M., Shoji, T., Kanda, H., Maekawa, K., Nishizawa, Y., Morii, H. Correlation between the intima-media thickness of carotid artery and aortic pulse wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care 1999, 22, 1851-1857. [CrossRef] [PubMed]
15. Kimoto, E., Shoji, T., Shinohara, K., Inaba, M., Okuno, Y., Miki, T., Koyama, H., Emoto, M., Nishizawa, Y. Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes 2003, 52, 448-452. [CrossRef] [PubMed]
16. De Angelis, L., Millasseau, S.C., Smith, A., Viberti, G., Jones, R.H., Ritter, J.M., Chowienczyk, P.J. Sex differences in age-related stiffening of aorta in subjects with type 2 diabetes. Hypertension 2004, 44, 67-71. [CrossRef] [PubMed]
17. Stehouwer, C.D., Henry, R.M., Ferreira, I. Arterial stiffness in diabetes and the metabolic syndrome: A pathway to cardiovascular disease. Diabetologia 2008, 51, 527-539. [CrossRef] [PubMed]
18. Ishimura, E., Taniwaki, H., Tsuchida, T., Obatake, N., Emoto, M., Shoji, T., Shioi, A., Inaba, M., Nishizawa, Y. Urinary albumin excretion associated with arterial stiffness rather than thickness in type 2 diabetes. J. Nephrol. 2007, 20, 204-211. [PubMed]
19. Rema, M., Mohan, V., Deepa, R., Ravikumar, R. Chennai urban rural epidemiology study-2. Association of carotid intima-thickness and arterial stiffness with diabetic retinopathy: The Chennai Urban Rural Epidemiology Study (CURES-2). Diabetes Care 2004, 27, 1962-1967. [CrossRef] [PubMed]
20. Cardoso, C.R., Ferreira, M.T., Leite, N.C., Barros, P.N., Conte, P.H., Salles, G.F. Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients. Atherosclerosis 2009, 205, 472-476. [CrossRef] [PubMed]
21. Kim, E.S., Moon, S.D., Kim, H.S., Lim, D.J., Cho, J.H., Kwon, H.S., Ahn, C.W., Yoon, K.H., Kang, M.I., Cha, B.Y., et al. Diabetic peripheral neuropathy is associated with increased arterial stiffness without changes in carotid intima-media thickness in type 2 diabetes. Diabetes Care 2011, 34, 1403-1405. [CrossRef] [PubMed]
22. Ha, B.K., Kim, B.G., Kim, D.H., Lee, S.I., Jung, S.M., Park, J.Y., Lee, C.W., Kim, S.S., Kim, B.H., Kim, I.J. Relationships between brachial-ankle pulse wave velocity and peripheral neuropathy in type 2 diabetes. Diabetes Metab. J. 2012, 36, 443-451. [CrossRef] [PubMed]
23. Yokoyama, H., Yokota, Y., Tada, J., Kanno, S. Diabetic neuropathy is closely associated with arterial stiffening and thickness in type 2 diabetes. Diabet. Med. 2007, 24, 1329-1335. [CrossRef] [PubMed]
24. Meyer, C., Milat, F., McGrath, B.P., Cameron, J., Kotsopoulos, D., Teede, H.J. Vascular dysfunction and autonomic neuropathy in Type 2 diabetes. Diabet. Med. 2004, 21, 746-751. [CrossRef] [PubMed]
25. Theilade, S., Lajer, M., Persson, F., Joergensen, C., Rossing, P. Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes. Diabetes Care 2013, 36, 715-721. [CrossRef] [PubMed]
26. Kim, W.J., Park, C.Y., Park, S.E., Rhee, E.J., Lee, W.Y., Oh, K.W., Park, S.W., Kim, S.W., Song, S. The association between regional arterial stiffness and diabetic retinopathy in type 2 diabetes. Atherosclerosis 2012, 225, 237-241. [CrossRef] [PubMed]
27. Smith, A., Karalliedde, J., de Angelis, L., Goldsmith, D., Viberti, G. Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J. Am. Soc. Nephrol. 2005, 16, 1069-1075. [CrossRef] [PubMed]
28. Liu, J.J., Tavintharan, S., Yeoh, L.Y., Sum, C.F., Ng, X.W., Pek, S.L., Lee, S.B., Tang, W.E., Lim, S.C., SMART2D Study. High normal albuminuria is independently associated with aortic stiffness in patients with Type 2 diabetes. Diabet. Med. 2014, 31, 1199-1204. [CrossRef] [PubMed]
29. Yokoyama, H., Aoki, T., Imahori, M., Kuramitsu, M. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity. Kidney Int. 2004, 66, 448-454. [CrossRef] [PubMed]
30. Kim, K.J., Lee, B.W., Kim, H.M., Shin, J.Y., Kang, E.S., Cha, B.S., Lee, E.J., Lim, S.K., Lee, H.C. Associations between cardio-ankle vascular index and microvascular complications in type 2 diabetes mellitus patients. J. Atheroscler. Thromb. 2011, 18, 328-336. [CrossRef] [PubMed]
31. Aoun, S., Blacher, J., Safar, M.E., Mourad, J.J. Diabetes mellitus and renal failure: Effects on large artery stiffness. J. Hum. Hypertens. 2001, 15, 693-700. [CrossRef] [PubMed]
32. Sjöblom, P., Nystrom, F.H., Länne, T., Engvall, J., Östgren, C.J. Microalbuminuria, but not reduced eGFR, is associated with cardiovascular subclinical organ damage in type 2 diabetes. Diabetes Metab. 2014, 40, 49-55. [CrossRef] [PubMed]
33. Bouchi, R., Babazono, T., Mugishima, M., Yoshida, N., Nyumura, I., Toya, K., Hanai, K., Tanaka, N., Ishii, A., Uchigata, Y., et al. Arterial stiffness is associated with incident albuminuria and decreased glomerular filtration rate in type 2 diabetic patients. Diabetes Care 2011, 34, 2570-2575. [CrossRef] [PubMed]
34. Cardoso, C.R., Moran, C.B., Marinho, F.S., Ferreira, M.T., Salles, G.F. Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort study. Diabetologia 2015, 58, 2161-2168. [CrossRef] [PubMed]
35. Boutouyrie, P., Tropeano, A.I., Asmar, R., Gautier, I., Benetos, A., Lacolley, P., Laurent, S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension 2002, 39, 10-15. [CrossRef] [PubMed]
36. Blacher, J., Guerin, A.P., Pannier, B., Marchais, S.J., Safar, M.E., London, G.M. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99, 2434-2439. [CrossRef] [PubMed]
37. Sutton-Tyrrell, K., Najjar, S.S., Boudreau, R.M., Venkitachalam, L., Kupelian, V., Simonsick, E.M., Havlik, R., Lakatta, E.G., Spurgeon, H., Kritchevsky, S., et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 2005, 111, 3384-3390. [CrossRef] [PubMed]
38. Willum-Hansen, T., Staessen, J.A., Torp-Pedersen, C., Rasmussen, S., Thijs, L., Ibsen, H., Jeppesen, J. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006, 113, 664-670. [CrossRef] [PubMed]
39. Mitchell, G.F., Hwang, S.J., Vasan, R.S., Larson, M.G., Pencina, M.J., Hamburg, N.M., Vita, J.A., Levy, D., Benjamin, E.J. Arterial stiffness and cardiovascular events: The Framingham heart study. Circulation 2010, 121, 505-511. [CrossRef] [PubMed]
40. Vlachopoulos, C., Aznaouridis, K., Stefanadis, C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis. J. Am. Coll. Cardiol. 2010, 55, 1318-1327. [CrossRef] [PubMed]
41. Cruickshank, K., Riste, L., Anderson, S.G., Wright, J.S., Dunn, G., Gosling, R.G. Aortic pulse wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation 2002, 106, 2085-2090. [CrossRef] [PubMed]
42. Cardoso, C.R., Salles, G.F. Aortic stiffness: Is it time to be included into clinical diabetes management? J. Diabetes Complicat. 2016, 30, 1207-1208. [CrossRef] [PubMed]
43. Van Bortel, L.M., Laurent, S., Boutouyrie, P., Chowienczyk, P., Cruickshank, J.K., de Backer, T., Filipovsky, J., Huybrechts, S., Mattace-Raso, F.U., Protogerou, A.D., et al. Expert consensus document on the measurement of aortic stiffness in daily practice using carotid-femoral pulse wave velocity. J. Hypertens. 2012, 30, 445-448. [CrossRef] [PubMed]
44. The Reference Values for Arterial Stiffness’ Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘Establishing normal and reference values’. Eur. Heart J. 2010, 31, 2338-2350.
45. Ferreira, M.T., Leite, N.C., Cardoso, C.R., Salles, G.F. Correlates of aortic stiffness progression in patients with type 2 diabetes: Importance of glycemic control: The Rio de Janeiro type 2 diabetes cohort study. Diabetes Care 2015, 38, 897-904. [CrossRef] [PubMed]
46. Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., de Backer, G., Dominiczak, A., et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 2013, 31, 1281-1357. [CrossRef] [PubMed]
47. Kovacic, J.C., Moreno, P., Hachinski, V., Nabel, E.G., Fuster, V. Cellular senescence, vascular disease, and aging: Part 1 of a 2-part review. Circulation 2011, 123, 1650-1660. [CrossRef] [PubMed]
48. Kovacic, J.C., Moreno, P., Hachinski, V., Nabel, E.G., Fuster, V. Cellular senescence, vascular disease, and aging: Part 2 of a 2-part review: Clinical vascular disease in the elderly. Circulation 2011, 123, 1900-1910. [CrossRef] [PubMed]
49. Rask-Madsen, C., Kahn, C.R. Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 2012, 32, 2052-2059. [CrossRef] [PubMed]
50. Avogaro, A., de Kreutzenberg, S.V., Federici, M., Fadini, G.P. The endothelium abridges insulin resistance to premature aging. J. Am. Heart Assoc. 2013, 2, e000262. [CrossRef] [PubMed]
51. Costantino, S., Paneni, F., Cosentino, F. Ageing, metabolism and cardiovascular disease. J. Physiol. 2016, 594, 2061-2073. [CrossRef] [PubMed]
52. Rubin, J., Nambi, V., Chambless, L.E., Steffes, M.W., Juraschek, S.P., Coresh, J., Sharrett, A.R., Selvin, E. Hyperglycemia and arterial stiffness: The Atherosclerosis Risk in the Communities study. Atherosclerosis 2012, 225, 246-251. [CrossRef] [PubMed]
53. Teoh, W.L., Price, J.F., Williamson, R.M., Payne, R.A., van Look, L.A., Reynolds, R.M., Frier, B.M., Wilkinson, I.B., Webb, D.J., Strachan, M.W., et al. Metabolic parameters associated with arterial stiffness in older adults with type 2 diabetes: The Edinburgh type 2 diabetes study. J. Hypertens. 2013, 31, 1010-1017. [CrossRef] [PubMed]
54. Pfeifle, B., Ditschuneit, H. Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 1981, 20, 155-158. [CrossRef] [PubMed]
55. Kass, D.A., Shapiro, E.P., Kawaguchi, M., Capriotti, A.R., Scuteri, A., de Groof, R.C., Lakatta, E.G. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker. Circulation 2001, 104, 1464-1470. [CrossRef] [PubMed]
56. Utescu, M.S., Couture, V., Mac-Way, F., de Serres, S.A., Marquis, K., Larivière, R., Desmeules, S., Lebel, M., Boutouyrie, P., Agharazii, M. Determinants of progression of aortic stiffness in hemodialysis patients: A prospective longitudinal study. Hypertension 2013, 62, 154-160. [CrossRef] [PubMed]
57. Lakatta, E.G. Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises: Part III: Cellular and molecular clues to heart and arterial aging. Circulation 2003, 107, 490-497. [CrossRef] [PubMed]
58. Perret-Guillaume, C., Joly, L., Jankowski, P., Benetos, A. Benefits of the RAS blockade: Clinical evidence before the ONTARGET study. J. Hypertens. 2009, 27, S3-S7. [CrossRef] [PubMed]
59. Williams, B., Lacy, P.S., Thom, S.M., Cruickshank, K., Stanton, A., Collier, D., Hughes, A.D., Thurston, H., O’Rourke, M., CAFE Investigators, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the conduit artery function evaluation (CAFE) study. Circulation 2006, 113, 1213-1225. [CrossRef] [PubMed]
60. Mallareddy, M., Parikh, C.R., Peixoto, A.J. Effect of angiotensin converting enzyme inhibitors on arterial stiffness in hypertension: Systematic review and meta-analysis. J. Clin. Hypertens. (Greenwich) 2006, 8, 398-403. [CrossRef]
61. Sohn, S.I., Kim, C.J. Modulation of renin-angiotensin system and arterial stiffness: Evidence from clinical trials. Curr. Hypertens. Rev. 2014, 10, 37-40. [CrossRef] [PubMed]
62. Cooper, M.E. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001, 44, 1957-1972. [CrossRef] [PubMed]
63. Sjølie, A.K., Dodson, P., Hobbs, F.R. Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review. Int. J. Clin. Pract. 2011, 65, 148-153. [CrossRef] [PubMed]
64. Persson, F., Lindhardt, M., Rossing, P., Parving, H.H. Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review. J. Renin Angiotensin Aldosterone Syst. 2016, 17, 3. [CrossRef] [PubMed]
65. Petersen, K.S., Blanch, N., Keogh, J.B., Clifton, P.M. Effect of weight loss on pulse wave velocity: Systematic review and meta-analysis. Arterioscler. Thromb. Vasc. Biol. 2015, 35, 243-252. [CrossRef] [PubMed]
66. Madden, K.M., Lockhart, C., Cuff, D., Potter, T.F., Meneilly, G.S. Short-term aerobic exercise reduces arterial stiffness in older adults with type 2 diabetes, hypertension, and hypercholesterolemia. Diabetes Care 2009, 32, 1531-1535. [CrossRef] [PubMed]
67. Yokoyama, H., Emoto, M., Fujiwara, S., Motoyama, K., Morioka, T., Koyama, H., Shoji, T., Inaba, M., Nishizawa, Y. Short-term aerobic exercise improves arterial stiffness in type 2 diabetes. Diabetes Res. Clin. Pract. 2004, 65, 85-93. [CrossRef] [PubMed]
68. Loimaala, A., Groundstroem, K., Rinne, M., Nenonen, A., Huhtala, H., Parkkari, J., Vuori, I. Effect of long-term endurance and strength training on metabolic control and arterial elasticity in patients with type 2 diabetes mellitus. Am. J. Cardiol. 2009, 103, 972-977. [CrossRef] [PubMed]
69. Way, K.L., Keating, S.E., Baker, M.K., Chuter, V.H., Johnson, N.A. The effect of exercise on vascular function and stiffness in type 2 diabetes: A systematic review and meta-analysis. Curr. Diabetes Rev. 2016, 12, 369-383. [CrossRef] [PubMed]
70. Hiukka, A., Westerbacka, J., Leinonen, E.S., Watanabe, H., Wiklund, O., Hulten, L.M., Salonen, J.T., Tuomainen, T.P., Yki-Järvinen, H., Keech, A.C., et al. Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus. J. Am. Coll. Cardiol. 2008, 52, 2190-2197. [CrossRef] [PubMed]
71. Mills, C.E., Govoni, V., Faconti, L., Morant, S., Casagrande, M.L., Maskell, P., Masani, A., Crickmore, H., Iqbal, F., Webb, A.J., et al. Reducing arterial stiffness independently of blood pressure: Proof or concept? The randomized, factorial ‘VASERA’ trial. J. Hypertens. 2016, 34 (Suppl 2), e112. [CrossRef]
72. Tahara, N., Yamagishi, S.I., Bekki, M., Kodama, N., Nakamura, T., Sugiyama, Y., Oshige, T., Kumashiro, Y., Honda, A., Tahara, A., et al. Anagliptin, a dipeptidyl peptidase-4 inhibitor, ameliorates arterial stiffness in association with reduction of remnant-like particle cholesterol and alanine transaminase levels in type 2 diabetic patients. Curr. Vasc. Pharmacol. 2016, 14, 552-562. [CrossRef] [PubMed]
73. Guerin, A.P., Blacher, J., Pannier, B., Marchais, S.J., Safar, M.E., London, G.M. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001, 103, 987-992. [CrossRef] [PubMed]